Clinical Trial Update: Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating postoperative transarterial chemoembolization for hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Zhejiang University | Conditions: Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization | Phase 3 | Status: COMPLETED